HomeOpen Access NewsVaccinations

Vaccinations

Subscribe to Updates

University of Oxford launches first human aerosol TB vaccine trial

Diseases & Conditions
The University of Oxford has commenced a new clinical trial called TB-45, which will test the safety of a new tuberculosis (TB) vaccine.

Inflammation from COVID-19 can cause multi-organ damage

Health & Social Care
Severe cases of inflammation from COVID-19 can occur in some people – leading to cases of acute respiratory distress and multi-organ damage.

Understanding Flaviviruses: Deciphering insect-borne virus strategies

Diseases & Conditions
Understanding the infection strategy of mosquito-borne viruses known as flaviviruses is key in the future development of treatments and possible vaccines

Non-English speaking patients have 35% higher chance of COVID death

Health & Social Care
Non-English speaking patients with COVID have a higher likelihood of needing ICU care and dying from the virus, say US scientists.

Scientists develop Omicron variant vaccine against COVID

Research & Innovation
MedUni Vienna delivers promising data to the Omicron variant vaccine which could protect people against all known variants of the SARS-CoV-2 virus.

Which is the better protection against COVID-19? Immunity or vaccination?

Health & Social Care
Researchers find the best protection against COVID-19 is vaccinations rather than natural immunity, when analysing how infection with SARS-CoV-2 affects the immune system.

Survivors with COVID-19 pneumonia take one year to heal

Health & Social Care
People who survive COVID-19 pneumonia, take at least one year to heal their lungs, according to a study published in Radiology.

Pregnancy and COVID vaccine: Mothers can protect unborn baby from virus 

Health & Social Care
In the context of pregnancy and COVID vaccines, a study finds that vaccination does not create complicated birth outcomes.

Global COVID-19 responses could help to end HIV

Health & Social Care
Global COVID-19 responses could serve as a coordinated approach to end the HIV pandemic - bettering global immunisation to both viruses.

Therapeutic feline and canine cancer vaccine

Cancer Research
Here we learn from Biljana Stangeland, PhD, Executive Director, Chief Scientific Officer and Co-founder at Alv B AS, about exciting new developments in therapeutic feline and canine cancer vaccine.

Can mice be an effective model animal for Covid-19?

Diseases & Conditions
Examining existing approved compounds to treat Covid-19 can significantly speed up the development of drugs.

Clinical trials begin for three mRNA HIV vaccines

Health & Social Care
The National Institute of Allergy and Infectious Diseases (NIAID) has launched Phase 1 clinical trials for three mRNA HIV vaccines.

Pfizer will donate profits from Russia to “humanitarian support”

Research & Innovation
Pfizer said all profits from Russia would go to "humanitarian support" for Ukraine, with future clinical trials now off the table.

Three vaccine doses give 86% efficacy against Omicron variant

Pharma
Data finds that three vaccine doses can give 86% protection against the Omicron variant, reducing the chances of severe COVID-19 and death.

Moderna signs agreement for first mRNA factory in Africa

Research & Innovation
Separate to WHO efforts to conduct a technology transfer, Moderna signed a Memorandum of Understanding with Kenya to build the first mRNA factory in Africa.

Increased vaccine inequalities in UK ethnic minority groups

Health & Social Care
COVID vaccine rollout led to vaccine inequalities in UK ethnic minority groups, with a decline in people’s willingness to take up vaccination.

What are the five main Omicron symptoms? 

Health & Social Care
In this article, we explain the five main Omicron symptoms - while looking at why the variant is still dominant in global public health.
1...456...26Page 5 of 26

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders

Visit Article Archive
Open Access Government

Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.

Follow Us

Resources

Quick Links

Legal & Marketing

As a Crossref Sponsored Member we are able to connect your content with a global network of online scholarly research, currently over 20,000 other organizational members from 160 countries. Crossref drive metadata exchange and support nearly 2 billion monthly API queries, facilitating global research communication.

© Adjacent Digital Politics Ltd